Growth Metrics

Beta Bionics (BBNX) Receivables - Net (2023 - 2025)

Beta Bionics (BBNX) has disclosed Receivables - Net for 3 consecutive years, with $17.3 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 42.62% to $17.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.3 million through Dec 2025, up 42.62% year-over-year, with the annual reading at $17.3 million for FY2025, 42.62% up from the prior year.
  • Receivables - Net hit $17.3 million in Q4 2025 for Beta Bionics, up from $11.7 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $17.3 million in Q4 2025 to a low of $4.4 million in Q4 2023.
  • Historically, Receivables - Net has averaged $11.0 million across 3 years, with a median of $11.6 million in 2025.
  • Biggest five-year swings in Receivables - Net: soared 172.3% in 2024 and later soared 42.62% in 2025.
  • Year by year, Receivables - Net stood at $4.4 million in 2023, then skyrocketed by 172.3% to $12.1 million in 2024, then soared by 42.62% to $17.3 million in 2025.
  • Business Quant data shows Receivables - Net for BBNX at $17.3 million in Q4 2025, $11.7 million in Q3 2025, and $11.5 million in Q2 2025.